Icahn looks likely to squeeze a higher price from the Karfunkel-Zyskind family and Stone Point for AmTrust
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free Trial
  • Log in

Icahn looks likely to squeeze a higher price from the Karfunkel-Zyskind family and Stone Point for AmTrust

Patient AmTrust investors unaligned with the controlling Karfunkel-Zyskind family may yet find themselves the beneficiaries of Carl Icahn’s protests over the deal being offered to take the insurer private.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Gift this article